一家想让外骨骼成为「人体器官」的公司，再获亿元级融资

Core Viewpoint - The exoskeleton industry is expected to evolve into an independent sector comparable to smartphones, addressing human mobility limitations and enhancing physical capabilities [2]. Group 1: Company Developments - Cheng Tian Technology secured a significant B+ round financing led by Agricultural Bank Capital, marking its second funding round in a year [2]. - The company plans to launch consumer-grade exoskeleton products in 2025, with an estimated shipment of 60,000 to 100,000 units in 2026 [3][9]. - The initial consumer product, a passive exoskeleton, sold out quickly, indicating strong market demand [7]. Group 2: Product Features and User Feedback - The passive exoskeleton targets individuals with walking disabilities, receiving positive feedback for improving stability and gait, although it has limitations in high-load scenarios like climbing [7]. - Active exoskeletons are being developed to assist with joint pain and fatigue during physical activities, with applications in scenic areas [8]. - The company emphasizes the importance of user-specific needs, suggesting that different demographics require tailored exoskeleton solutions [14][15]. Group 3: Market Trends and Future Outlook - The exoskeleton market is still in its infancy, with significant growth potential driven by aging populations and increasing consumer interest [10][18]. - The company aims to differentiate its products through precise user profiling and targeted functionalities rather than creating a one-size-fits-all solution [12][14]. - AI applications in exoskeletons focus on enhancing human-machine interaction and personalizing user experiences through data-driven insights [24][25]. Group 4: Supply Chain and Production Challenges - The supply chain for exoskeleton components has improved, allowing for better cost control and scalability, which was previously a major barrier [11]. - The company has opted for in-house manufacturing to address the rapid product iteration demands and ensure quality standards [11][12]. - The core indicators for consumer-grade exoskeletons include weight, battery life, and stability, which are influenced by supply chain capabilities [12]. Group 5: Integration of AI and Advanced Technologies - AI is being utilized for personalized adaptations of exoskeletons, enhancing user experience through real-time data analysis [24][25]. - The company is also developing brain-machine interfaces to further integrate exoskeletons with human physiology, aiming to improve rehabilitation outcomes [31][32]. - Continuous data collection from clinical applications is crucial for refining product designs and enhancing user adaptability [30].